CanSino Biologics, Inc. Class H (HK:6185) has released an update.
CanSino Biologics Inc. has announced its 2023 Annual General Meeting (AGM) scheduled for June 27, 2024, where key points include the election of directors, approval of financial reports, and proposed amendments to the shareholders’ dividend plan. The AGM will also address the re-appointment of Deloitte as auditor and discuss the approval of bank credit line increases for 2024. Additionally, the meeting will consider granting the board a General Mandate to issue and deal with additional shares, reflecting a new share capital structure.
For further insights into HK:6185 stock, check out TipRanks’ Stock Analysis page.
